Porciso, Bb Boy -.
HRN: 21-35-08 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2022
AMPICILLIN 500MG (VIAL)
05/21/2022
05/28/2022
IV
145mg
Q12
PSNB (Thickly MSAF)
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes